0000899243-19-028374.txt : 20191202
0000899243-19-028374.hdr.sgml : 20191202
20191202205729
ACCESSION NUMBER: 0000899243-19-028374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191202
FILED AS OF DATE: 20191202
DATE AS OF CHANGE: 20191202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hasara Garrison J.
CENTRAL INDEX KEY: 0001510349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13467
FILM NUMBER: 191264417
MAIL ADDRESS:
STREET 1: 324 S. HYDE PARK AVENUE
STREET 2: SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibitor Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042418
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 541641133
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE
STREET 2: SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
BUSINESS PHONE: (813) 864-2559
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE
STREET 2: SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
FORMER COMPANY:
FORMER CONFORMED NAME: HedgePath Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130816
FORMER COMPANY:
FORMER CONFORMED NAME: COMMONWEALTH BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 19970714
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-02
0
0001042418
Inhibitor Therapeutics, Inc.
INTI
0001510349
Hasara Garrison J.
4830 W. KENNEDY BLVD., SUITE 600
TAMPA
FL
33609
0
1
0
0
CFO and Treasurer
Common Stock
2019-12-02
4
P
0
13500
0.07
A
3972544
D
The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at a per share price equal to $0.07 and $0.068. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Garrison J. Hasara
2019-12-02